Pedro Rosa Neto, M.D., Ph.D.

Professor

Endowed Title: Dear Scholar in Neurosciences; Dorothy L. and John P. Harbin Chair in Alzheimer's Disease Research
Schools: Medical School | Graduate School
Departments: Peter O'Donnell Jr. Brain Institute | Neurology | Radiology
Graduate Programs: Neuroscience

Biography

Joined UT Southwestern: 2025

Research: Dr. Rosa-Neto's research efforts are centered on biochemically important neuroimaging and fluid biomarkers in neurodegenerative disorders (especially in Alzheimer’s dementia). This area of investigation is critically important in the era of novel therapies for neurodegenerative disorders. He has expertise in quantification of brain function using imaging techniques, in particular positron emission tomography (PET).

Leadership: Dr. Rosa-Neto is the Director and PI of the North Texas- Alzheimer's Disease Research Center (NT-ADRC).

Research Interest

Alzheimer's Dementia

Publications

Amygdala and hippocampal contributions to broad autism phenotype: Project Ice Storm: Li X, Qureshi MN, Laplante DP, Elgbeili G, Jones SL, King S, Rosa-Neto P Translational psychiatry 2026 Dec 16
Functional network phenotypes of mild behavioural impairment: cognitive effects moderated by amyloid: Ng KP, Chong JS, Lussier F, Therriault J, Rahmouni N, Savard M, Stevenson J, Pascoal T, Gauthier S, Rosa-Neto P, Zhou JH Alzheimer's Research and Therapy 2026 Dec 18
Oral body temperature and cerebrospinal fluid pTau181 in older adults at increased risk of Alzheimer’s disease: Author Collaboration tP, Pillet P, Tremblay-Mercier J, Picard C, Rosa-Neto P, Villeneuve S, Poirier J, Calon F Neurobiology of Aging 2026 Nov 167 25-28
Hypertension acts together with Aβ pathology in late-life to promote memory loss: Author Collaboration AD, Da Ros LU, Ferrari-Souza JP, de Bastiani MA, Hauschild LA, Bellaver B, Ferreira PC, Leffa DT, Povala G, Lussier FZ, Chamoun M, Bezgin G, Benedet AL, Rahmouni N, Macedo AC, Blennow K, Ashton N, Zetterberg H, Borelli WV, Souza DO, Pascoal TA, Rosa-Neto P, Zimmer ER Journal of Prevention of Alzheimer's Disease 2026 Aug 13
In vivo-measured Lewy body pathology is associated with neuropsychiatric symptoms across the Alzheimer’s disease continuum: Leffa DT, Povala G, Ferreira PC, Ferrari-Souza JP, Bauer-Negrini G, Rodrigues MS, Amaral L, Lussier FZ, Medeiros MS, Soares C, Aguzzoli CS, Macedo AC, Therriault J, Rosa-Neto P, Tudorascu DL, Zimmer ER, Bellaver B, Pascoal TA Molecular psychiatry 2026 May 31 2472-2480
Eligibility for anti-amyloid treatment in a multiethnic community-based study: Trudel L, Therriault J, Macedo AC, Meeker KL, Braskie MN, Toga AW, Gauthier S, Vitali P, Schindler SE, O'Bryant SE, Rosa-Neto P Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring 2026 Apr 18
Estimated prevalence of underdiagnosed dementia in a multiethnic community-based study: Trudel L, Therriault J, Macedo AC, Braskie MN, Meeker KL, Toga AW, Gauthier S, Vitali P, O’Bryant SE, Rosa-Neto P Journal of Prevention of Alzheimer's Disease 2026 Apr 13
Analytical and clinical validation of the Lumipulse G plasma p-tau217 assay for clinical implementation: Arslan B, Gobom J, Andreasson U, Montoliu-Gaya L, Benedet AL, Dittrich A, Kern S, Skoog I, Ashton NJ, Chan T, Rahmouni N, Rosa-Neto P, Blennow K, Zetterberg H, Kvartsberg H Alzheimer's and Dementia 2026 Apr 22
Reader Response: The Great Debate in Diagnosing Alzheimer Disease: More Than Just a β Test: Bieger A, Brum WS, Borelli WV, Ferrari-Souza JP, DaCosta JC, Castilhos RM, Schumacher Schuh AF, Pascoal T, Rosa-Neto P, Schilling LP, Zimmer ER Neurology 2026 Mar 106
Quality Gaps in Online Media Coverage of Antiamyloid Monoclonal Antibodies for Alzheimer Disease: Macedo AC, de Lima AG, Miaw IS, Bizzi IH, Balbino JM, Therriault J, Zimmer ER, Ghezzi P, Rosa-Neto P JAMA Network Open 2026 Mar 9 e265026